IDECIDE-HOSPICE for Hospice Care Awareness

Age: 65+

Sex: Any

Trial Phase: Academic

Sponsor: University of Colorado, Denver

Disqualifiers: Cognitive impairment, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 4

400 Participants Needed

Trial Summary

What is the purpose of this trial?

This study will sample older Black adults to test their knowledge and opinions of hospice.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment IDECIDE-HOSPICE for hospice care awareness?

Research shows that hospice care can improve patient experiences and outcomes, such as symptom management and quality of life, which suggests that treatments like IDECIDE-HOSPICE may also be effective in enhancing hospice care awareness and outcomes. ^{1 2 3 4 5}

How does the IDECIDE-HOSPICE treatment differ from other hospice care options?

The IDECIDE-HOSPICE treatment focuses on increasing awareness and understanding of hospice care, particularly among community-dwelling elderly and rural populations, which is unique compared to traditional hospice care that primarily focuses on end-of-life support. This approach aims to address barriers to accessing hospice services by improving knowledge and reducing misconceptions about hospice care. ^{6 7 8 9 10}

Research Team

Channing E Tate, PhD, MPH

Principal Investigator

University of Colorado School of Medicine

Eligibility Criteria

This clinical trial is for older Black adults to explore their understanding and attitudes towards hospice care. Specific eligibility criteria are not provided, so it's important to contact the study organizers for detailed information on who can participate.

Inclusion Criteria

Identifies as Black or African American

Can read and write English

Exclusion Criteria

I am unable to understand and give consent for medical procedures due to cognitive impairment.

Unable to read/write English

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants review the PtDA decision tool and complete surveys to assess knowledge and attitudes toward hospice

3 months

2 visits (in-person or virtual)

Control

Control group participants complete surveys and review an attention control activity booklet

3 months

2 visits (in-person or virtual)

Follow-up

Participants are monitored for changes in knowledge and attitudes toward hospice

4 weeks

Treatment Details

Interventions

• IDECIDE-HOSPICE

Trial Overview The intervention being tested in this trial is called IDECIDE-HOSPICE, which likely involves educational or decision-making aids designed to inform participants about hospice care options.

Participant Groups

Group I: Interview Experimental Treatment 1 Intervention

20 of the 200 Intervention participants will complete an interview using qualitative methods surrounding the topic of hospice care and the PtDA.

Group II: Intervention Experimental Treatment 1 Intervention

200 participants reviewed the PtDA decision tool for education on hospice care and subsequently completed a second survey which was identical to the first.

Group III: Control Active Control 1 Intervention

200 of the 400 participants completed two identical surveys one month apart but did NOT review the PtDA decision tool prior to completing the second survey timepoint. Instead, these participants reviewed an 8-page attention control activity booklet. These participants are used as a control group in assessing any change in knowledge or opinions of hospice after the intervention group reviewed the PtDA.

Who Is Running the Clinical Trial?

University of Colorado, Denver

Lead Sponsor

Trials

1,842

Recruited

3,028,000+

Findings from Research

A study analyzing data from 19,747 hospice/palliative care patients over three years showed significant improvements in various patient outcomes, including symptom control and family care, although pain management did not improve.

The findings indicate that systematic data collection and feedback have led to better and more consistent patient outcomes in hospice/palliative care services across Australia.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Improving national hospice/palliative care service symptom outcomes systematically through point-of-care data collection, structured feedback and benchmarking. Currow, DC., Allingham, S., Yates, P., et al.[2021]

In Australia, over 85% of patients referred to specialized hospice/palliative care services have cancer, highlighting the importance of these services in cancer care, with data collected from 5,395 patients across 6,379 admissions.

The Palliative Care Outcomes Collaboration (PCOC) revealed significant variations in patient outcomes, such as stability after an unstable phase (12-fold differences) and improvements in symptom scores (seven-fold differences), indicating the need for ongoing data collection and benchmarking in palliative care.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Is it feasible and desirable to collect voluntarily quality and outcome data nationally in palliative oncology care? Currow, DC., Eagar, K., Aoun, S., et al.[2008]

In a study of 65 hospice and palliative care patients, 78% had events that led to their admission, and 62% experienced additional adverse events during their stay, highlighting the prevalence of symptomatic adverse events in this population.

The study found an average of 0.13 adverse events per patient per day, indicating that even in the absence of initial events, patients are at high risk for complications, which can worsen their overall health status.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Adverse events in hospice and palliative care: a pilot study to determine feasibility of collection and baseline rates. Currow, DC., Agar, MR., To, TH., et al.[2011]

References

1. England pubmed.ncbi.nlm.nih.gov

Exploring the association of hospice care on patient experience and outcomes of care. [2020]

2. Germany pubmed.ncbi.nlm.nih.gov

Improving national hospice/palliative care service symptom outcomes systematically through point-of-care data collection, structured feedback and benchmarking. [2021]

3. United States pubmed.ncbi.nlm.nih.gov

Is it feasible and desirable to collect voluntarily quality and outcome data nationally in palliative oncology care? [2008]

4. Korea (South) pubmed.ncbi.nlm.nih.gov

[Development and evaluation of "Hospice Smart Patient" service program]. [2011]

5. United States pubmed.ncbi.nlm.nih.gov

Adverse events in hospice and palliative care: a pilot study to determine feasibility of collection and baseline rates. [2011]

6. Netherlands pubmed.ncbi.nlm.nih.gov

Place of death for hospice-cared terminal patients with cancer: A nationwide retrospective study in Taiwan. [2019]

7. United States pubmed.ncbi.nlm.nih.gov

Awareness of Hospice Care Among Community-Dwelling Elderly Participants. [2023]

8. United States pubmed.ncbi.nlm.nih.gov

Hospice education about people with AIDS as terminally ill patients: coping with a new epidemic of death. [2018]

9. United States pubmed.ncbi.nlm.nih.gov

Barriers to accessing hospice services before a late terminal stage. [2019]

10. United States pubmed.ncbi.nlm.nih.gov

Awareness of Hospice Care Among Rural African-Americans: Findings From Social Determinants of Health Framework. [2022]